A research team at the Institute for Basic Science (IBS) has identified a previously unknown enzyme, SIRT2, that plays a key ...

A comprehensive review explores how gut microbiota diversity and fitness influence Alzheimer’s disease (AD) risk through ...

There's new research linking senolytics to helping slow down Alzheimer's progression. Here's how and what experts have to say ...

Neurodegenerative diseases like Alzheimer’s and ALS involve different proteins, but they share a key problem: the proteins ...

Ultrasound therapy is emerging as a potential treatment for Alzheimer’s disease. It uses ultrasound to open the blood-brain ...

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease (PD) and anti-tau therapies, which are ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

A groundbreaking study from Yale-NUS College has revealed a new way of thinking about Alzheimer’s disease, a condition that ...

Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.